Molecular Formula | C15H11ClFN5
|
Molar Mass | 315.73 |
Density | 1.387±0.06 g/cm3(Predicted) |
Boling Point | 491.5±55.0 °C(Predicted) |
pKa | 1.75±0.63(Predicted) |
Storage Condition | -20℃ |
Use | AZD4635 (HTL1071) is an effective selective, orally active adenosine A2A receptor (A2AR) antagonist. AZD4635 Ki binding to human A2AR is 1.7 nM, and the selectivity for A2AR is more than 30 times that of other adenosine receptors. |
In vitro study | In CHO cells stably expressing A2AR of human origin, AZD4625 inhibited the generation of IC50 of 0.79, 10.0 and 142.9 nM with the addition of 0.1, 1 and 10 μm adenosine, respectively. |
In vivo study | Inhibition of A2AR by AZD4625 can reduce tumor burden and enhance anti-tumor immunity. |